(DSFIR) DSM-Firmenich - Ratings and Ratios

Exchange: AS • Country: Switzerland • Currency: EUR • Type: Common Stock • ISIN: CH1216478797

DSFIR: Flavors, Fragrances, Vitamins, Minerals, Enzymes, Probiotics

DSM-Firmenich AG is a global leader in nutrition, health, and beauty, operating across Switzerland, the Netherlands, Europe, the Middle East, Africa, North America, Latin America, China, and Asia. The company is structured into four key segments: Perfumery & Beauty, Taste, Texture & Health, Health, Nutrition & Care, and Animal Nutrition & Health.

The Perfumery & Beauty segment specializes in creating scents using natural, synthetic, and biotech ingredients, catering to the fragrance needs of global beauty and personal care brands. This segment is a major player in the perfume and fragrance industry, leveraging cutting-edge technology to create unique and sustainable scent solutions.

The Taste, Texture & Health segment focuses on food and beverage solutions, offering a wide range of products including natural flavorings, sugar reduction solutions, and food enzymes. This segment is critical for food manufacturers looking to enhance taste, improve texture, and meet growing consumer demand for healthier and more sustainable food options.

The Animal Nutrition & Health segment provides innovative solutions for the animal production industry, including high-quality animal proteins, performance-enhancing feed additives, and data-driven precision services. This segment is vital for ensuring the health and productivity of livestock, poultry, and aquaculture, with a strong emphasis on sustainability and animal welfare.

The Health, Nutrition & Care segment delivers solutions for early life nutrition, dietary supplements, pharmaceuticals, and biomedical materials. This segment offers a diverse portfolio of products, including vitamins, nutritional lipids, minerals, carotenoids, and probiotics, as well as premix solutions and personalized nutrition offerings. It also provides regulatory affairs and formulation expertise, making it a one-stop-shop for companies in the health and nutrition space.

Founded in 1902 and headquartered in Kaiseraugst, Switzerland, DSM-Firmenich AG has a long history of innovation and leadership in its industries. The company is well-positioned to capitalize on growing trends in health, wellness, and sustainability, making it an attractive investment opportunity for investors looking for exposure to these sectors.

From an investment perspective, DSM-Firmenich AG offers a unique combination of stability, growth potential, and innovation. With a market capitalization of 27,798.18M EUR and a forward P/E ratio of 21.60, the company is valued at a premium, reflecting its strong market position and growth prospects. The P/S ratio of 2.10 indicates a reasonable valuation relative to its revenue, while the P/B ratio of 1.20 suggests that the company’s assets are being valued at a modest premium to their book value.

For investors and fund managers, DSM-Firmenich AG represents a compelling opportunity to invest in a company with a diversified portfolio of businesses, a strong track record of innovation, and a commitment to sustainability. The company’s exposure to fast-growing markets in health, nutrition, and beauty, combined with its leadership in animal nutrition and perfume technologies, makes it a well-rounded investment proposition with significant upside potential.

Ticker Symbol: DSFIR

Exchange: AS

Additional Sources for DSFIR Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

DSFIR Stock Overview

Market Cap in USD 30,119m
Sector Basic Materials
Industry Specialty Chemicals
GiC Sub-Industry Personal Care Products
IPO / Inception

DSFIR Stock Ratings

Growth 5y -20.0%
Fundamental -29.5%
Dividend 57.6%
Rel. Strength Industry -17.2
Analysts -
Fair Price Momentum 83.22 EUR
Fair Price DCF 49.78 EUR

DSFIR Dividends

Dividend Yield 12m 2.62%
Yield on Cost 5y 2.29%
Annual Growth 5y 25.00%
Payout Consistency 100.0%

DSFIR Growth Ratios

Growth Correlation 3m 15.6%
Growth Correlation 12m -21.9%
Growth Correlation 5y 43.9%
CAGR 5y -9.40%
CAGR/Max DD 5y -0.26
Sharpe Ratio 12m -1.62
Alpha -14.93
Beta 0.47
Volatility 28.98%
Current Volume 500.7k
Average Volume 20d 516.6k
What is the price of DSFIR stocks?
As of March 12, 2025, the stock is trading at EUR 93.46 with a total of 500,736 shares traded.
Over the past week, the price has changed by -8.64%, over one month by -7.00%, over three months by -11.03% and over the past year by -8.26%.
Is DSM-Firmenich a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, DSM-Firmenich (AS:DSFIR) is currently (March 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -29.52 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DSFIR as of March 2025 is 83.22. This means that DSFIR is currently overvalued and has a potential downside of -10.96%.
Is DSFIR a buy, sell or hold?
DSM-Firmenich has no consensus analysts rating.
What are the forecast for DSFIR stock price target?
According to ValueRays Forecast Model, DSFIR DSM-Firmenich will be worth about 91.1 in March 2026. The stock is currently trading at 93.46. This means that the stock has a potential downside of -2.5%.
Issuer Forecast Upside
Wallstreet Target Price 132.2 41.5%
Analysts Target Price - -
ValueRay Target Price 91.1 -2.5%